Bicocca Open Archive

Logo unimib boa
MASSERINI, MASSIMO ERNESTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.925
AS - Asia 9.029
EU - Europa 8.417
SA - Sud America 1.272
AF - Africa 234
OC - Oceania 36
Continente sconosciuto - Info sul continente non disponibili 25
Totale 36.938
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.228
SG - Singapore 3.076
CN - Cina 2.432
DE - Germania 1.406
IT - Italia 1.289
SE - Svezia 1.186
HK - Hong Kong 1.095
RU - Federazione Russa 1.012
BR - Brasile 943
IE - Irlanda 875
VN - Vietnam 809
UA - Ucraina 709
CA - Canada 600
GB - Regno Unito 568
IN - India 426
FR - Francia 332
FI - Finlandia 262
PL - Polonia 178
KR - Corea 162
BD - Bangladesh 149
AT - Austria 117
AR - Argentina 112
TR - Turchia 108
IQ - Iraq 104
ZA - Sudafrica 97
DK - Danimarca 84
JP - Giappone 84
NL - Olanda 82
ID - Indonesia 75
ES - Italia 71
BE - Belgio 69
IR - Iran 68
PK - Pakistan 65
MX - Messico 62
SA - Arabia Saudita 53
PH - Filippine 52
VE - Venezuela 45
BG - Bulgaria 40
CO - Colombia 38
EC - Ecuador 37
UZ - Uzbekistan 36
AU - Australia 31
MY - Malesia 31
CL - Cile 28
PT - Portogallo 28
EG - Egitto 23
EU - Europa 23
JO - Giordania 22
NP - Nepal 22
TW - Taiwan 22
KE - Kenya 21
PY - Paraguay 21
MA - Marocco 19
CH - Svizzera 18
PE - Perù 18
AE - Emirati Arabi Uniti 17
CZ - Repubblica Ceca 17
TH - Thailandia 17
IL - Israele 16
RO - Romania 15
UY - Uruguay 15
BO - Bolivia 13
LT - Lituania 13
OM - Oman 13
TN - Tunisia 13
DZ - Algeria 12
ET - Etiopia 12
JM - Giamaica 12
LB - Libano 10
AZ - Azerbaigian 8
KZ - Kazakistan 8
GR - Grecia 7
HU - Ungheria 7
AL - Albania 6
AO - Angola 6
BH - Bahrain 6
DO - Repubblica Dominicana 6
LY - Libia 6
SN - Senegal 6
GE - Georgia 5
MD - Moldavia 5
BY - Bielorussia 4
CI - Costa d'Avorio 4
CY - Cipro 4
KG - Kirghizistan 4
LK - Sri Lanka 4
NZ - Nuova Zelanda 4
AM - Armenia 3
BB - Barbados 3
EE - Estonia 3
GT - Guatemala 3
MO - Macao, regione amministrativa speciale della Cina 3
MU - Mauritius 3
NO - Norvegia 3
PA - Panama 3
PS - Palestinian Territory 3
QA - Qatar 3
RS - Serbia 3
SY - Repubblica araba siriana 3
YE - Yemen 3
Totale 36.897
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.238
Singapore 1.763
Ashburn 1.619
Woodbridge 1.577
Chandler 1.058
Hong Kong 1.056
San Jose 887
Houston 884
Dublin 852
Fairfield 833
Frankfurt am Main 758
Jacksonville 753
Wilmington 614
Dearborn 597
Milan 553
Beijing 423
Seattle 401
New York 395
Santa Clara 364
Cambridge 297
Toronto 292
Princeton 278
Los Angeles 270
Dallas 240
Chicago 238
Nanjing 224
Ho Chi Minh City 221
The Dalles 212
Hefei 197
Hanoi 174
Shanghai 174
Seoul 136
Lauterbourg 128
Lachine 127
Kraków 114
Lawrence 110
Helsinki 108
Altamura 103
Council Bluffs 102
Guangzhou 100
Vienna 99
Buffalo 98
São Paulo 89
Moscow 86
Nanchang 82
Hangzhou 77
Orem 71
Boardman 69
Ottawa 67
San Diego 66
Brussels 63
Changsha 61
Tokyo 56
Dong Ket 55
Andover 52
Tianjin 50
Chennai 49
Fremont 49
Shenyang 47
London 43
Wayne 43
Rome 40
Warsaw 40
Da Nang 39
Johannesburg 39
Baghdad 38
Falls Church 38
Plovdiv 37
Hebei 36
Jakarta 36
Jiaxing 36
Jinan 36
Montreal 36
Brooklyn 35
Manchester 34
Munich 34
Atlanta 33
Zhengzhou 33
Mountain View 31
Nürnberg 31
Stockholm 30
New Delhi 29
Tashkent 29
Denver 28
Kunming 28
Mumbai 28
Amsterdam 27
Auburn Hills 27
Rio de Janeiro 27
Columbus 26
Dhaka 26
Salt Lake City 25
Norwalk 24
Lahore 23
Pune 23
Ankara 21
Belo Horizonte 21
Boston 21
Grafing 21
Haiphong 21
Totale 24.029
Salva come PNG Salva come JPEG
Nome #
Functionalization with TAT-peptide enhances blood-brain barrier crossing in vitro of nanoliposomes carrying a curcumin-derivative to bind amyloid-β peptide 715
Evolution of Nanoparticle Protein Corona across the Blood-Brain Barrier 567
Investigation of Functionalized Poly(N,N-dimethylacrylamide)-block-polystyrene Nanoparticles As Novel Drug Delivery System to Overcome the Blood-Brain Barrier in Vitro 475
Novel Antitransferrin Receptor Antibodies Improve the Blood-Brain Barrier Crossing Efficacy of Immunoliposomes 466
Multifunctional liposomes interact with Abeta in human biological fluids: Therapeutic implications for Alzheimer's disease 455
Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer's Aβ peptide 440
THE TOXICITY OF AMYLOID-BETA OLIGOMERS AND TAU HYPERPHOSPHORYLATION ARE PREVENTED FROM LIPID-BASED NANOPARTICLES IN HUMAN PRIMARY FIBOBLASTS 427
The ability of liposomes, tailored for blood-brain barrier targeting, to reach the brain is dramatically affected by the disease state 427
Modulation of the intrinsic neuronal excitability by multifunctional liposomes tailored for treatment of Alzheimer’s disease 423
Nanomedicine for the treatment of Alzheimer's disease 419
Morphogenic effect of common solvent in the self-assembly behavior of amphiphilic PEO-b-PLA 415
Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model 412
Evaluation of gold nanoparticles biocompatibility: a multiparametric study on cultured endothelial cells and macrophages 404
Enhanced brain targeting of engineered solid lipid nanoparticles 391
Multifunctional liposomes delay phenotype progression and prevent memory impairment in a presymptomatic stage mouse model of Alzheimer disease 390
Solid Lipid Nanoparticles: a strategy to overcome the blood-brain barrier 368
Lipid-based nanoparticles counteract the oligomer abeta toxicity and tau phosphorylation in an ex-vivo biomolecular model of alzheimer disease 366
Versatile and efficient targeting using a single nanoparticulate platform: Application to cancer and alzheimer's disease 355
Prion protein structure is affected by pH-dependent interaction with membranes: a study in a model system 344
18F-labeling syntheses and preclinical evaluation of functionalized nanoliposomes for Alzheimer's disease 344
Beta Amyloid Aggregation Inhibitors: Small Molecules as Candidate Drugs for Therapy of Alzheimer Disease 343
Curcumin derivatives as new ligands of Aβ peptides 343
Characterization of prion protein-enriched domains, isolated from rat cerebellar granule cells in culture 336
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 334
Developmental changes in the protein composition of sphingolipid- and cholesterol-enriched membrane domains of rat cerebellar granule cells 333
Iron oxide nanoparticles surface coating and cell uptake affect biocompatibility and inflammatory responses of endothelial cells and macrophages 333
TrkA pathway activation induced by amyloid-beta (Abeta) 332
Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood-brain-barrier: Implications for therapy of Alzheimer disease 331
Functionalized liposomes and phytosomes loading Annona muricata L. aqueous extract: Potential nanoshuttles for brain-delivery of phenolic compounds 329
Protein-functionalized nanoparticles derived from end-functional polymers and polymer prodrugs for crossing the blood-brain barrier 324
Aβ42 production in brain capillary endothelial cells after oxygen and glucose deprivation 321
Multifunctional liposomes reduce brain β-amyloid burden and ameliorate memory impairment in alzheimer’s disease mouse models 317
Functionalization with ApoE-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide 316
Solid Lipid Nanoparticles: a strategy to overcome the blood-brain barrier 310
Amyposomes: a nanomedicine designed for treatment of Alzheimer disease 305
Abeta peptide toxicity is reduced after treatments decreasing phosphatidylethanolamine content in differentiated neuroblastoma cells 302
Liposomes functionalized to overcome the blood-brain barrier and to target amyloid-β peptide: The chemical design affects the permeability across an in vitro model 301
Effect of modified collagen on amyloid beta peptide aggregation 300
Effect of nanoparticles binding ß-amyloid peptide on nitric oxide production by cultured endothelial cells and macrophages 299
Pin1, a new player in the fate of HIF-1α degradation: an hypothetical mechanism inside vascular damage as Alzheimer’s disease risk factor 296
Membrane features and activity of GPI-anchored enzymes: alkaline phosphatase reconstituted in model membranes 295
A nanomedicine-based therapeutic approach restores memory and ameliorates amyloid pathology in Alzheimer's mouse models 295
Palmitic is the main fatty acid carried by lipids of detergent-resistant membrane fractions from neural and non-neural cells 291
Detection and Characterization of Different Brain-Derived Subpopulations of Plasma Exosomes by Surface Plasmon Resonance Imaging 285
Beta-amyloid (25-35) enhances lipid metabolism and protein ubiquitination in cultured neurons 282
Study of the effects of nanoliposomes engineered for the treatment of Alzheimer's disease on the electrical activity of cortical neurons 277
mApoE-Functionalized Nanoliposomes Delivering Doxorubicin and Ultrasmall Superparamagnetic Iron Oxide to Glioblastoma Cells Characterized by TEM and Confocal Microscopy 276
Enhanced folate binding of cultured fibroblasts from Alzheimer's disease patients 275
Role of lipid rafts and GM1 in the segregation and processing of Prion Protein 272
Enhanced brain targeting of engineered solid lipid nanoparticles 271
Lipid-based nanoparticles as a potential tool to deplete abeta. Toward new therapeutic strategies for Alzheimer’s disease? 270
Enhanced GM1 ganglioside catabolism in cultured fibroblasts from Alzheimer patients 268
Ceramides and sphingomyelinases in senile plaques 267
Immunoseparation of Prion protein-enriched domains from other detergent-resistant membrane fractions, isolated from neuronal cells 266
Pin1 affects Tau phosphorylation in response to Abeta oligomers 265
Age-related changes in the ceramide composition of the major gangliosides present in rat brain subcellular fractions enriched in plasma membranes of neuronal and myelin origin 263
Fuc-GM1 ganglioside mimics the receptor function of GM1 for cholera toxin 259
THE TOXIC EFFECT OF ABETA OLIGOMERS MAY BE REDUCED BY LIPID-BASED NANOPARTICLES IN HUMAN EX-VIVO MODELS 259
Functionalization with curcumin-derivative and TAT peptide enhances the interaction with human brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide 258
Two tail-anchored protein variants, differing in transmembrane domain length and intracellular sorting, interact differently with lipids 255
Inhibition of murine leukemia (WEHI-3B and L1210) proliferation by cholera toxin B subunit 255
A Novel Retro-Inverso Peptide Inhibitor Reduces Amyloid Deposition, Oxidation and Inflammation and Stimulates Neurogenesis in the APPswe/PS1 Delta E9 Mouse Model of Alzheimer's Disease 255
Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's Aβ peptide 253
Repeated intraperitoneal injections of liposomes containing phosphatidic acid and cardiolipin reduce amyloid-β levels in APP/PS1 transgenic mice 253
Role of phosphatidylethanol in membranes. Effects on membrane fluidity, tolerance to ethanol, and activity of membrane-bound enzymes 252
Dependence of rat liver CMP-N-acetylneuraminate:GM1 sialyltransferase (SAT IV) activity on the ceramide composition of GM1 ganglioside 252
Pin1: A new outlook in alzheimer's disease 252
Nanomedicine for the treatment of Alzheimer's disease 251
Raman spectroscopy uncovers biochemical tissue-related features of extracellular vesicles from mesenchymal stromal cells 251
Lipid-based nanoparticles with high binding affinity for amyloid-b1e42 peptide 249
Interactions of proteins with ganglioside-enriched microdomains on the membrane: the lateral phase separation of molecular species of GD1a ganglioside, having homogeneous long-chain base composition, is recognized by Vibrio cholerae sialidase 248
AUTOPHAGY ALTERATION UNDER ISCHEMIC CONDITION: A POSSIBLE LINK TO ALZHEIMER'S DISEASE 248
Ischemic conditions and β-secretase activation: The impact of membrane cholesterol enrichment as triggering factor in rat brain endothelial cells 245
Amyposomes, a nanotechnological chaperone with anti-amyloidogenic activity 243
A photo-reactive derivative of ganglioside GM1 specifically cross-links VIP21-caveolin on the cell surface 243
Nanotechnology for neurodegenerative disorders 243
Abnormal cross-talk between mutant presenilin 1 (I143T, G384A) and glycosphingolipid biosynthesis 243
ALCOHOL AND NEURAL LIPIDS 240
Synthesis of functionalized [F-18]liposomes for preclinical PET imaging in Alzheimer's disease 239
Nanoparticle-based strategy to cross the BBB: the potential for the therapy of Alzheimer’s disease 239
Liposomes functionalized with acidic lipids rescue Aβ-induced toxicity in murine neuroblastoma cells 237
Radiation and adjuvant drug-loaded liposomes target glioblastoma stem cells and trigger in-situ immune response 236
Thermotropic behavior of fatty acid ethyl esters in phospholipid liposomes 236
Multi-functional liposomes prevent memory impairment and slow down brain B-amyloid deposition in a mouse model of Alzheimer’s disease. 236
Methyl-β-cyclodextrin treatment affects the thermotropic behaviour of membranes and detergent-resistant membrane fractions of cultured A431 cells 234
The binding affinity of anti-Aβ1-42 MAb-decorated nanoliposomes to Aβ1-42 peptides in vitro and to amyloid deposits in post-mortem tissue 234
Lipid-based nanoparticles (NPs) with high binding affinity for amyloid-beta1-42 peptide modulate the barrier properties of a monolayer of endothelial cells 234
Binding of lipid-based nanoparticles to plasma abeta: relevance for new therapeutic strategies in Alzheimer’s disease 233
Stability of Aβ (1-42) peptide fibrils as consequence of environmental modifications 232
The interaction of complement system with abeta-binding liposomes: towards engineering of safer vesicles for the management of alzheimer's disease 230
Early-Stage Diagnosis of Endogenous Diseases by Swarms of Nanobots: An Applicative Scenario 229
Nuovi composti triciclici glicofusi, procedimento per la loro produzione e loro impiego quali ligandi dei peptidi β amiloidi (Aβ) 229
Attempt of neuroprotective response of rat cultured hippocampal neurons against Abeta insult 228
Changes in the composition of detergent-resistant membrane domains of cultured neurons following protein kinase C activation 228
Antibody-functionalized polymer nanoparticle leading to memory recovery in Alzheimer's disease-like transgenic mouse model 227
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 226
Association to HeLa cells and surface behavior of exogenous gangliosides studied with a fluorescent derivative of GM1 225
A surveillance system for early-stage diagnosis of endogenous diseases by swarms of nanobots 224
Influence of glycolipid oligosaccharide and long-chain base composition on the thermotropic properties of dipalmitoylphosphatidylcholine large unilamellar vesicles containing gangliosides 218
Applicability of [11C]PIB micro-PET imaging for in vivo follow-up of anti-amyloid treatment effects in APP23 mouse model 217
Totale 30.004
Salva come PNG Salva come JPEG
Categoria #
all - tutte 114.663
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 114.663
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021297 0 0 0 0 0 0 0 0 0 0 96 201
2021/20221.838 98 167 176 189 76 175 142 100 104 169 158 284
2022/20233.854 449 1.198 338 396 230 562 37 220 260 25 86 53
2023/20242.561 66 84 137 146 328 678 554 121 158 33 37 219
2024/20254.641 244 541 267 214 430 210 259 213 418 716 380 749
2025/202611.264 1.268 639 1.094 1.285 1.496 658 1.713 564 1.046 1.156 345 0
Totale 37.626